{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05966740",
            "orgStudyIdInfo": {
                "id": "1160-0309"
            },
            "organization": {
                "fullName": "Boehringer Ingelheim",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study in the United Sates That Looks at the Safety and Effectiveness of Pradaxa Pellets in Children Aged 3 Months to Less Than 12 Years Who Need Treatment of a Blood Clot or Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot",
            "officialTitle": "Safety and Effectiveness of Pradaxa Oral Pellet Formulation for Treatment of Acute Venous Thromboembolic Events (VTE) and/or for Risk Reduction of Recurrence of VTE in Pediatric Patients Aged 3 Months to Less Than 12 Years in a Real World Setting: a Prospective Non-interventional Study Conducted in the United States",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-study-in-the-united-sates-that-looks-at-the-safety-and-effectiveness-of-pradaxa-pellets-in-children-aged-months-to-less-than-years-who-need-treatment-of-a-blood-clot-or-who-have-had-a-blood-clot-and-are-at-risk-of-developing-another-blood-clot"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-10-31",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2029-06-28",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2029-06-28",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-07-21",
            "studyFirstSubmitQcDate": "2023-07-21",
            "studyFirstPostDateStruct": {
                "date": "2023-08-01",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-26",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-27",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Boehringer Ingelheim",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "Children's Hospital Acquired Thrombosis consortium",
                    "class": "UNKNOWN"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The main research question of this study is to obtain further safety and effectiveness data on Pradaxa Pellets in children aged 3 months to less than 12 years in routine clinical practice setting."
        },
        "conditionsModule": {
            "conditions": [
                "Venous Thromboembolism"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 330,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Pediatric patients with VTE and/or at risk for VTE"
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Cumulative incidence of clinically relevant bleeding events",
                    "timeFrame": "Up to week 52"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Occurrence of recurrent Venous Thromboembolic Event (VTE)",
                    "timeFrame": "Up to week 52"
                },
                {
                    "measure": "Mortality related to thrombotic or thromboembolic events",
                    "timeFrame": "Up to week 52"
                },
                {
                    "measure": "Occurence of all bleeding events",
                    "timeFrame": "Up to week 52"
                },
                {
                    "measure": "Occurrence of post-thrombotic syndrome (PTS)",
                    "timeFrame": "Up to week 52"
                },
                {
                    "measure": "Incidence of adverse events (AEs)",
                    "timeFrame": "Up to week 52"
                },
                {
                    "measure": "Incidence of serious adverse events (SAEs)",
                    "timeFrame": "Up to week 52"
                },
                {
                    "measure": "Thrombotic burden at the end of the treatment period vs baseline, i.e. image-based resolution status of the thrombus (complete response, partial response, stable disease, progressive disease)",
                    "timeFrame": "Baseline and up to week 12"
                },
                {
                    "measure": "Recurrence of VTE while on treatment",
                    "timeFrame": "Up to week 52"
                },
                {
                    "measure": "Duration of treatment with dabigatran etexilate",
                    "timeFrame": "Up to week 52"
                },
                {
                    "measure": "Compliance with dabigatran etexilate treatment",
                    "timeFrame": "Up to week 52"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\nPediatric patients aged 3 months to less than 12 years at the time of Pradaxa Pellets initiation\n\n* Written informed consent from parents/care givers and patient assent if age appropriate\n* Initiation of Pradaxa Pellets administration either as initial or subsequent therapy:\n\n  * Treatment of VTE\n  * Treatment to reduce the risk of recurrence of VTE\n\nExclusion Criteria:\n\n* Participation in any randomized clinical trial or use of investigational product, participation in any other observational study is not an exclusion\n* Any contraindications to Pradaxa Pellets according to the US Prescribing Information.\n* Previous participation in this study.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "3 Months",
            "maximumAge": "12 Years",
            "stdAges": [
                "CHILD"
            ],
            "studyPopulation": "Pediatric patients aged 3 months to less than 12 years, who may be considered for anticoagulation with Pradaxa Pellets due to venous thromboembolic events (VTE), are usually treated in neonatology, pediatric general surgery, cardiac surgery or intensive care units. Pediatric patients with anticoagulation with Pradaxa Pellets for the prevention of recurrent VTE are usually evaluated by pediatric hematologists in pediatric hematology units. Any of these patients that are prescribed Pradaxa pellets may be considered for inclusion into this study.",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Boehringer Ingelheim",
                    "role": "CONTACT",
                    "phone": "1-800-243-0127",
                    "email": "clintriage.rdg@boehringer-ingelheim.com"
                }
            ],
            "locations": [
                {
                    "facility": "University of California, San Diego",
                    "status": "RECRUITING",
                    "city": "La Jolla",
                    "state": "California",
                    "zip": "92093",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "00441144040048",
                            "email": "support@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.84727,
                        "lon": -117.2742
                    }
                },
                {
                    "facility": "Rady Children's Hospital",
                    "status": "RECRUITING",
                    "city": "San Diego",
                    "state": "California",
                    "zip": "92123",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "00441144040048",
                            "email": "support@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.71533,
                        "lon": -117.15726
                    }
                },
                {
                    "facility": "Indiana Hemophilia & Thrombrosis Center",
                    "status": "RECRUITING",
                    "city": "Indianapolis",
                    "state": "Indiana",
                    "zip": "46260",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "00441144040048",
                            "email": "support@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.76838,
                        "lon": -86.15804
                    }
                },
                {
                    "facility": "Cincinnati Children's Hospital",
                    "status": "RECRUITING",
                    "city": "Cincinnati",
                    "state": "Ohio",
                    "zip": "45229",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "00441144040048",
                            "email": "support@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.12713,
                        "lon": -84.51435
                    }
                },
                {
                    "facility": "Dayton Children's Hospital",
                    "status": "RECRUITING",
                    "city": "Dayton",
                    "state": "Ohio",
                    "zip": "45404",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "00441144040048",
                            "email": "support@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.75895,
                        "lon": -84.19161
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Related Info",
                    "url": "https://www.mystudywindow.com"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Once the criteria in section \"Time Frame\" are fulfilled, researchers can use the following link https://www.mystudywindow.com/msw/datasharing to request access to the clinical study documents regarding this study, and upon a signed \"Document Sharing Agreement\".\n\nFurthermore, researchers can request access to the clinical study data, for this and other listed studies, after the submission of a research proposal and according to the terms outlined in the website.",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP",
                "CSR"
            ],
            "timeFrame": "After structured results have been posted, all regulatory activities are completed in the US and EU for the product and indication, and after the primary manuscript has been accepted for publication.",
            "accessCriteria": "For study documents - upon signing of a 'Document Sharing Agreement'.\n\nFor study data - 1. after the submission and approval of the research proposal (checks will be performed by the sponsor and/or the independent review panel, including checking that the planned analysis does not compete with sponsor's publication plan); 2. and upon signing of a legal agreement.",
            "url": "https://www.mystudywindow.com/msw/datasharing"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000013923",
                    "term": "Thromboembolism"
                },
                {
                    "id": "D000054556",
                    "term": "Venous Thromboembolism"
                }
            ],
            "ancestors": [
                {
                    "id": "D000016769",
                    "term": "Embolism and Thrombosis"
                },
                {
                    "id": "D000014652",
                    "term": "Vascular Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M14850",
                    "name": "Recurrence",
                    "relevance": "LOW"
                },
                {
                    "id": "M16686",
                    "name": "Thrombosis",
                    "relevance": "LOW"
                },
                {
                    "id": "M16682",
                    "name": "Thromboembolism",
                    "asFound": "Thromboembolism",
                    "relevance": "HIGH"
                },
                {
                    "id": "M27780",
                    "name": "Venous Thromboembolism",
                    "asFound": "Venous Thromboembolism",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7784",
                    "name": "Embolism",
                    "relevance": "LOW"
                },
                {
                    "id": "M19128",
                    "name": "Embolism and Thrombosis",
                    "relevance": "LOW"
                },
                {
                    "id": "M17400",
                    "name": "Vascular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T170",
                    "name": "Acute Graft Versus Host Disease",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M490",
                    "name": "Dabigatran",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "AnCoag",
                    "name": "Anticoagulants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}